This topic contains a solution. Click here to go to the answer

Author Question: Team Shirts has current assets of 162,348; total assets of 210,837; current liabilities of 86,941; ... (Read 121 times)

ARLKQ

  • Hero Member
  • *****
  • Posts: 571
Team Shirts has current assets of 162,348; total assets of 210,837; current liabilities of 86,941; total liabilities of 101,745; and shareholders' equity of 109,092. Calculate the debt-to-equity ratio.
 
  A) 188
  B) 53
  C) 93
  D) 193

Question 2

For a strong internal control system over cash, it is important to have the duties related to cash receipts and cashpayments divided among different employees.
 a. True
  b. False
 
   Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Jordin Calloway

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

C

Answer to Question 2

True




ARLKQ

  • Member
  • Posts: 571
Reply 2 on: Jul 5, 2018
Wow, this really help


diana chang

  • Member
  • Posts: 288
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

It is important to read food labels and choose foods with low cholesterol and saturated trans fat. You should limit saturated fat to no higher than 6% of daily calories.

Did you know?

Urine turns bright yellow if larger than normal amounts of certain substances are consumed; one of these substances is asparagus.

Did you know?

On average, the stomach produces 2 L of hydrochloric acid per day.

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library